Europe Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024 - 2031
Published Date : 27-Aug-2024 |
Pages: 135 |
Formats: PDF |
COVID-19 Impact on the Europe Genomics In Cancer Care Market
Market Overview
The Europe Genomics In Cancer Care Market would witness market growth of 15.5% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,939.1 million by 2031. The UK market is exhibiting a CAGR of 14.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 16.4% during (2024 - 2031).
Genomic information allows for the personalization of chemotherapy regimens based on the genetic profile of the patient and the tumor. By identifying genetic variations that affect drug metabolism and efficacy, clinicians can tailor chemotherapy protocols to improve treatment effectiveness and reduce adverse effects, ensuring that each patient receives the most appropriate drugs.
Additionally, adoption of genomics in cancer care has significantly transformed the oncology landscape, driven personalized treatment approaches, and improved patient outcomes. Genomics is increasingly integrated into standard clinical practice as part of routine cancer care.
The high cancer rates in Europe lead to increased government funding and support for cancer research programs. European governments allocate more resources towards genomic research initiatives to understand cancer genomics and develop new treatments. Among the EU countries, the share of deaths from cancer in the total number of deaths in 2021 reached or exceeded 26.0 % in Denmark (28.2 %), Ireland (27.7 %), Slovenia (27.1 %) and the Netherlands (26.6 %). This share peaked at 30.7 % among males in Slovenia, followed by 29.5 % in Denmark.
Free Valuable Insights: The Global Genomics In Cancer Care Market will Hit USD 53.5 Billion by 2031, at a CAGR of 15.7%
Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- GE HealthCare Technologies, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
Europe Genomics In Cancer Care Market Report Segmentation
By Application
- Diagnostics
- Personalized Medicine
- Drug Discovery & Development
- Research
By Product
- Instruments
- Consumables
- Services
By Technology
- PCR
- Genome Sequencing
- Microarrays
- Nuclei Acid Extraction & Purification
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genomics In Cancer Care Market, by Application
1.4.2 Europe Genomics In Cancer Care Market, by Product
1.4.3 Europe Genomics In Cancer Care Market, by Technology
1.4.4 Europe Genomics In Cancer Care Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Genomics In Cancer Care Market by Application
5.1 Europe Diagnostics Market by Country
5.2 Europe Personalized Medicine Market by Country
5.3 Europe Drug Discovery & Development Market by Country
5.4 Europe Research Market by Country
Chapter 6. Europe Genomics In Cancer Care Market by Product
6.1 Europe Instruments Market by Country
6.2 Europe Consumables Market by Country
6.3 Europe Services Market by Country
Chapter 7. Europe Genomics In Cancer Care Market by Technology
7.1 Europe PCR Market by Country
7.2 Europe Genome Sequencing Market by Country
7.3 Europe Microarrays Market by Country
7.4 Europe Nuclei Acid Extraction & Purification Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Genomics In Cancer Care Market by Country
8.1 Germany Genomics In Cancer Care Market
8.1.1 Germany Genomics In Cancer Care Market by Application
8.1.2 Germany Genomics In Cancer Care Market by Product
8.1.3 Germany Genomics In Cancer Care Market by Technology
8.2 UK Genomics In Cancer Care Market
8.2.1 UK Genomics In Cancer Care Market by Application
8.2.2 UK Genomics In Cancer Care Market by Product
8.2.3 UK Genomics In Cancer Care Market by Technology
8.3 France Genomics In Cancer Care Market
8.3.1 France Genomics In Cancer Care Market by Application
8.3.2 France Genomics In Cancer Care Market by Product
8.3.3 France Genomics In Cancer Care Market by Technology
8.4 Russia Genomics In Cancer Care Market
8.4.1 Russia Genomics In Cancer Care Market by Application
8.4.2 Russia Genomics In Cancer Care Market by Product
8.4.3 Russia Genomics In Cancer Care Market by Technology
8.5 Spain Genomics In Cancer Care Market
8.5.1 Spain Genomics In Cancer Care Market by Application
8.5.2 Spain Genomics In Cancer Care Market by Product
8.5.3 Spain Genomics In Cancer Care Market by Technology
8.6 Italy Genomics In Cancer Care Market
8.6.1 Italy Genomics In Cancer Care Market by Application
8.6.2 Italy Genomics In Cancer Care Market by Product
8.6.3 Italy Genomics In Cancer Care Market by Technology
8.7 Rest of Europe Genomics In Cancer Care Market
8.7.1 Rest of Europe Genomics In Cancer Care Market by Application
8.7.2 Rest of Europe Genomics In Cancer Care Market by Product
8.7.3 Rest of Europe Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genomics In Cancer Care Market, by Application
1.4.2 Europe Genomics In Cancer Care Market, by Product
1.4.3 Europe Genomics In Cancer Care Market, by Technology
1.4.4 Europe Genomics In Cancer Care Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Genomics In Cancer Care Market by Application
5.1 Europe Diagnostics Market by Country
5.2 Europe Personalized Medicine Market by Country
5.3 Europe Drug Discovery & Development Market by Country
5.4 Europe Research Market by Country
Chapter 6. Europe Genomics In Cancer Care Market by Product
6.1 Europe Instruments Market by Country
6.2 Europe Consumables Market by Country
6.3 Europe Services Market by Country
Chapter 7. Europe Genomics In Cancer Care Market by Technology
7.1 Europe PCR Market by Country
7.2 Europe Genome Sequencing Market by Country
7.3 Europe Microarrays Market by Country
7.4 Europe Nuclei Acid Extraction & Purification Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Genomics In Cancer Care Market by Country
8.1 Germany Genomics In Cancer Care Market
8.1.1 Germany Genomics In Cancer Care Market by Application
8.1.2 Germany Genomics In Cancer Care Market by Product
8.1.3 Germany Genomics In Cancer Care Market by Technology
8.2 UK Genomics In Cancer Care Market
8.2.1 UK Genomics In Cancer Care Market by Application
8.2.2 UK Genomics In Cancer Care Market by Product
8.2.3 UK Genomics In Cancer Care Market by Technology
8.3 France Genomics In Cancer Care Market
8.3.1 France Genomics In Cancer Care Market by Application
8.3.2 France Genomics In Cancer Care Market by Product
8.3.3 France Genomics In Cancer Care Market by Technology
8.4 Russia Genomics In Cancer Care Market
8.4.1 Russia Genomics In Cancer Care Market by Application
8.4.2 Russia Genomics In Cancer Care Market by Product
8.4.3 Russia Genomics In Cancer Care Market by Technology
8.5 Spain Genomics In Cancer Care Market
8.5.1 Spain Genomics In Cancer Care Market by Application
8.5.2 Spain Genomics In Cancer Care Market by Product
8.5.3 Spain Genomics In Cancer Care Market by Technology
8.6 Italy Genomics In Cancer Care Market
8.6.1 Italy Genomics In Cancer Care Market by Application
8.6.2 Italy Genomics In Cancer Care Market by Product
8.6.3 Italy Genomics In Cancer Care Market by Technology
8.7 Rest of Europe Genomics In Cancer Care Market
8.7.1 Rest of Europe Genomics In Cancer Care Market by Application
8.7.2 Rest of Europe Genomics In Cancer Care Market by Product
8.7.3 Rest of Europe Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
List of Tables
TABLE 1 Europe Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 2 Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Genomics In Cancer Care Market
TABLE 4 Product Launches And Product Expansions– Genomics In Cancer Care Market
TABLE 5 Acquisition and Mergers– Genomics In Cancer Care Market
TABLE 6 Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 7 Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 8 Europe Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 9 Europe Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 10 Europe Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 11 Europe Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 12 Europe Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 13 Europe Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 14 Europe Research Market by Country, 2020 - 2023, USD Million
TABLE 15 Europe Research Market by Country, 2024 - 2031, USD Million
TABLE 16 Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 17 Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 18 Europe Instruments Market by Country, 2020 - 2023, USD Million
TABLE 19 Europe Instruments Market by Country, 2024 - 2031, USD Million
TABLE 20 Europe Consumables Market by Country, 2020 - 2023, USD Million
TABLE 21 Europe Consumables Market by Country, 2024 - 2031, USD Million
TABLE 22 Europe Services Market by Country, 2020 - 2023, USD Million
TABLE 23 Europe Services Market by Country, 2024 - 2031, USD Million
TABLE 24 Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 25 Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 26 Europe PCR Market by Country, 2020 - 2023, USD Million
TABLE 27 Europe PCR Market by Country, 2024 - 2031, USD Million
TABLE 28 Europe Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 29 Europe Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 30 Europe Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 31 Europe Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 32 Europe Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 33 Europe Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 34 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 35 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 36 Europe Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 37 Europe Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 38 Germany Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 39 Germany Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 40 Germany Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 41 Germany Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 42 Germany Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 43 Germany Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 44 Germany Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 45 Germany Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 46 UK Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 47 UK Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 48 UK Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 49 UK Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 50 UK Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 51 UK Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 52 UK Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 53 UK Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 54 France Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 55 France Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 56 France Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 57 France Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 58 France Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 59 France Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 60 France Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 61 France Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 62 Russia Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 63 Russia Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 64 Russia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 65 Russia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 66 Russia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 67 Russia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 68 Russia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 69 Russia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 70 Spain Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 71 Spain Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 72 Spain Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 73 Spain Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 74 Spain Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 75 Spain Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 76 Spain Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 77 Spain Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 78 Italy Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 79 Italy Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 80 Italy Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 81 Italy Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 82 Italy Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 83 Italy Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 84 Italy Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 85 Italy Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 86 Rest of Europe Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 87 Rest of Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 88 Rest of Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 89 Rest of Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 90 Rest of Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 91 Rest of Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 92 Rest of Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 93 Rest of Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 94 key Information – Agilent Technologies, Inc.
TABLE 95 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 96 Key Information – Danaher Corporation
TABLE 97 Key Information – Abbott Laboratories
TABLE 98 Key Information – Bio-Rad Laboratories, Inc.
TABLE 99 Key Information – GE HealthCare Technologies, Inc.
TABLE 100 Key information – Quest Diagnostics Incorporated
TABLE 101 Key Information – Revvity, Inc.
TABLE 102 Key Information – Eurofins Scientific SE
TABLE 103 Key Information – Hologic, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Genomics In Cancer Care Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Genomics In Cancer Care Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Key Strategic Move: (Mergers and Acquisitions : 2021, Jan – 2023, Jan) Leading Players
FIG 8 Porter’s Five Forces Analysis – Genomics In Cancer Care Market
FIG 9 Europe Genomics In Cancer Care Market share by Application, 2023
FIG 10 Europe Genomics In Cancer Care Market share by Application, 2031
FIG 11 Europe Genomics In Cancer Care Market by Application, 2020 - 2031, USD Million
FIG 12 Europe Genomics In Cancer Care Market share by Product, 2023
FIG 13 Europe Genomics In Cancer Care Market share by Product, 2031
FIG 14 Europe Genomics In Cancer Care Market by Product, 2020 - 2031, USD Million
FIG 15 Europe Genomics In Cancer Care Market share by Technology, 2023
FIG 16 Europe Genomics In Cancer Care Market share by Technology, 2031
FIG 17 Europe Genomics In Cancer Care Market by Technology, 2020 - 2031, USD Million
FIG 18 Europe Genomics In Cancer Care Market share by Country, 2023
FIG 19 Europe Genomics In Cancer Care Market share by Country, 2031
FIG 20 Europe Genomics In Cancer Care Market by Country, 2020 - 2031, USD Million
FIG 21 Swot Analysis: Agilent Technologies, Inc.
FIG 22 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 23 SWOT Analysis: Danaher Corporation
FIG 24 SWOT Analysis: Abbott Laboratories
FIG 25 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 26 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 27 SWOT Analysis: Quest Diagnostics Incorporated
FIG 28 Swot Analysis: Revvity, Inc.
FIG 29 SWOT Analysis: Eurofins Scientific SE
FIG 30 Swot Analysis: Hologic, Inc.
TABLE 2 Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Genomics In Cancer Care Market
TABLE 4 Product Launches And Product Expansions– Genomics In Cancer Care Market
TABLE 5 Acquisition and Mergers– Genomics In Cancer Care Market
TABLE 6 Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 7 Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 8 Europe Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 9 Europe Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 10 Europe Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 11 Europe Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 12 Europe Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 13 Europe Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 14 Europe Research Market by Country, 2020 - 2023, USD Million
TABLE 15 Europe Research Market by Country, 2024 - 2031, USD Million
TABLE 16 Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 17 Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 18 Europe Instruments Market by Country, 2020 - 2023, USD Million
TABLE 19 Europe Instruments Market by Country, 2024 - 2031, USD Million
TABLE 20 Europe Consumables Market by Country, 2020 - 2023, USD Million
TABLE 21 Europe Consumables Market by Country, 2024 - 2031, USD Million
TABLE 22 Europe Services Market by Country, 2020 - 2023, USD Million
TABLE 23 Europe Services Market by Country, 2024 - 2031, USD Million
TABLE 24 Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 25 Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 26 Europe PCR Market by Country, 2020 - 2023, USD Million
TABLE 27 Europe PCR Market by Country, 2024 - 2031, USD Million
TABLE 28 Europe Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 29 Europe Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 30 Europe Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 31 Europe Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 32 Europe Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 33 Europe Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 34 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 35 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 36 Europe Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 37 Europe Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 38 Germany Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 39 Germany Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 40 Germany Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 41 Germany Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 42 Germany Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 43 Germany Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 44 Germany Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 45 Germany Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 46 UK Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 47 UK Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 48 UK Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 49 UK Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 50 UK Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 51 UK Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 52 UK Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 53 UK Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 54 France Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 55 France Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 56 France Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 57 France Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 58 France Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 59 France Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 60 France Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 61 France Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 62 Russia Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 63 Russia Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 64 Russia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 65 Russia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 66 Russia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 67 Russia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 68 Russia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 69 Russia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 70 Spain Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 71 Spain Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 72 Spain Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 73 Spain Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 74 Spain Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 75 Spain Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 76 Spain Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 77 Spain Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 78 Italy Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 79 Italy Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 80 Italy Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 81 Italy Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 82 Italy Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 83 Italy Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 84 Italy Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 85 Italy Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 86 Rest of Europe Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 87 Rest of Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 88 Rest of Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 89 Rest of Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 90 Rest of Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 91 Rest of Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 92 Rest of Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 93 Rest of Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 94 key Information – Agilent Technologies, Inc.
TABLE 95 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 96 Key Information – Danaher Corporation
TABLE 97 Key Information – Abbott Laboratories
TABLE 98 Key Information – Bio-Rad Laboratories, Inc.
TABLE 99 Key Information – GE HealthCare Technologies, Inc.
TABLE 100 Key information – Quest Diagnostics Incorporated
TABLE 101 Key Information – Revvity, Inc.
TABLE 102 Key Information – Eurofins Scientific SE
TABLE 103 Key Information – Hologic, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Genomics In Cancer Care Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Genomics In Cancer Care Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Key Strategic Move: (Mergers and Acquisitions : 2021, Jan – 2023, Jan) Leading Players
FIG 8 Porter’s Five Forces Analysis – Genomics In Cancer Care Market
FIG 9 Europe Genomics In Cancer Care Market share by Application, 2023
FIG 10 Europe Genomics In Cancer Care Market share by Application, 2031
FIG 11 Europe Genomics In Cancer Care Market by Application, 2020 - 2031, USD Million
FIG 12 Europe Genomics In Cancer Care Market share by Product, 2023
FIG 13 Europe Genomics In Cancer Care Market share by Product, 2031
FIG 14 Europe Genomics In Cancer Care Market by Product, 2020 - 2031, USD Million
FIG 15 Europe Genomics In Cancer Care Market share by Technology, 2023
FIG 16 Europe Genomics In Cancer Care Market share by Technology, 2031
FIG 17 Europe Genomics In Cancer Care Market by Technology, 2020 - 2031, USD Million
FIG 18 Europe Genomics In Cancer Care Market share by Country, 2023
FIG 19 Europe Genomics In Cancer Care Market share by Country, 2031
FIG 20 Europe Genomics In Cancer Care Market by Country, 2020 - 2031, USD Million
FIG 21 Swot Analysis: Agilent Technologies, Inc.
FIG 22 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 23 SWOT Analysis: Danaher Corporation
FIG 24 SWOT Analysis: Abbott Laboratories
FIG 25 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 26 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 27 SWOT Analysis: Quest Diagnostics Incorporated
FIG 28 Swot Analysis: Revvity, Inc.
FIG 29 SWOT Analysis: Eurofins Scientific SE
FIG 30 Swot Analysis: Hologic, Inc.